A randomized, double‐blind, single‐dose study to assess bioequivalence of MB02 biosimilar after manufacturing iteration and reference bevacizumab

por Schwabe, C., Cole, A., Espigares‐Correa, A., Beydon, M. E., Florez‐Igual, A., Queiruga‐Parada, J.
Publicado 2023

MLVA typing of Mycoplasma hyopneumoniae bacterins and field strains

por Tamiozzo, P., Zamora, R., Lucchesi, P. M. A., Estanguet, A., Parada, J., Carranza, A., Camacho, P., Ambrogi, A.
Publicado 2015

A phase I/II dose-escalation multi-center study to evaluate the safety of infusion of natural killer cells or memory T cells as adoptive therapy in coronavirus pneumonia and/or lym...

por García-García, I., Guerra-García, P., Ferreras, C., Borobia, A. M., Carcas, A. J., Queiruga-Parada, J., Vicario, J. L., Mirones, I., Solano, C., Eguizabal, C., Soria, B., Pérez-Martínez, A.
Publicado 2021

Immunotherapy: EVALUATION OF MEMORY T CELLS AS ADOPTIVE THERAPY IN CORONAVIRUS PNEUMONIA AND/OR LYMPHOPENIA: A PHASE II CLINICAL TRIAL (RELEASE NCT04578210)

por Ferreras, C., Hernández, C., Martín-Quirós, A., Al-Akioui-Sanz, K., Mora-Rillo, M., Ibáñez, F., Goterris, R., de Paz, R., Guerra-García, P., Queiruga-Parada, J., Molina, P., Briones, M., Planelles, D., Borobia, A.M., Carcas, A., Vicario, J.L., Moreno, M., Balas, A., Eguizabal, C., Soria, B., Solano, C., Perez-Martinez, A.
Publicado 2023

Phase I dose-escalation single centre clinical trial to evaluate the safety of infusion of memory T cells as adoptive therapy in COVID-19 (RELEASE)

por Pérez-Martínez, A., Mora-Rillo, M., Ferreras, C., Guerra-García, P., Pascual-Miguel, B., Mestre-Durán, C., Borobia, A.M., Carcas, A.J., Queiruga-Parada, J., García, I., Sánchez-Zapardiel, E., Gasior, M., De Paz, R., Marcos, A., Vicario, J.L., Balas, A., Moreno, M.A., Eguizabal, C., Solano, C., Arribas, J.R., Buckley, R.de Miguel, Montejano, R., Soria, B.
Publicado 2021